H V Barron

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization
    H V Barron
    Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, USA
    Arch Intern Med 158:449-53. 1998
  2. ncbi Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Circulation 97:1150-6. 1998
  3. ncbi Effect of beta-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: data from a large HMO
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Am Heart J 134:608-13. 1997
  4. ncbi Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California San Francisco Medical Center, USA
    J Am Coll Cardiol 32:360-7. 1998
  5. ncbi Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
    B G Angeja
    Department of Medicine, University of California, San Francisco, California 94143, USA
    J Am Coll Cardiol 38:1297-301. 2001
  6. ncbi Use of reperfusion therapies in elderly patients with acute myocardial infarction
    B G Angeja
    Department of Medicine, University of California, San Francisco, Moffitt Hospital, 94143 0124, USA
    Drugs Aging 18:587-96. 2001
  7. ncbi Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2
    H V Barron
    Department of Medicine, University of California San Francisco, USA
    Am J Cardiol 85:294-8. 2000
  8. ncbi Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators
    A S Go
    Veterans Affairs Medical Center and University of California, San Francisco, 94121, USA
    Ann Intern Med 129:690-7. 1998
  9. ncbi The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2
    H V Barron
    University of California, San Francisco, USA
    Am Heart J 141:933-9. 2001
  10. ncbi Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Cardiol Rev 7:156-60. 1999

Detail Information

Publications12

  1. ncbi Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization
    H V Barron
    Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, USA
    Arch Intern Med 158:449-53. 1998
    ..Moreover, the dosages of beta-blockers used in randomized controlled trials appear to be much larger than those routinely prescribed...
  2. ncbi Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Circulation 97:1150-6. 1998
    ..However, several studies have suggested that many patients with an acute myocardial infarction do not receive this therapy. Whether this underutilization occurs in patients appropriate for such therapy remains unclear...
  3. ncbi Effect of beta-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: data from a large HMO
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Am Heart J 134:608-13. 1997
    ....
  4. ncbi Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California San Francisco Medical Center, USA
    J Am Coll Cardiol 32:360-7. 1998
    ....
  5. ncbi Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women
    B G Angeja
    Department of Medicine, University of California, San Francisco, California 94143, USA
    J Am Coll Cardiol 38:1297-301. 2001
    ..We examined the association of hormone therapy (HRT) with hemorrhagic and ischemic stroke among postmenopausal women with acute myocardial infarction (AMI)...
  6. ncbi Use of reperfusion therapies in elderly patients with acute myocardial infarction
    B G Angeja
    Department of Medicine, University of California, San Francisco, Moffitt Hospital, 94143 0124, USA
    Drugs Aging 18:587-96. 2001
    ..Finally, newer, more fibrin-specific thrombolytics may decrease the bleeding risk associated with thrombolytic therapy...
  7. ncbi Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2
    H V Barron
    Department of Medicine, University of California San Francisco, USA
    Am J Cardiol 85:294-8. 2000
    ....
  8. ncbi Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators
    A S Go
    Veterans Affairs Medical Center and University of California, San Francisco, 94121, USA
    Ann Intern Med 129:690-7. 1998
    ..Left bundle-branch block (BBB) is considered an important predictor of poor outcome in patients with acute myocardial infarction, but the consequences of right BBB are not well understood...
  9. ncbi The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2
    H V Barron
    University of California, San Francisco, USA
    Am Heart J 141:933-9. 2001
    ..The purpose of this study was to determine whether IABP use is associated with lower in-hospital mortality rates in patients with AMI complicated by cardiogenic shock in a large AMI registry...
  10. ncbi Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2
    H V Barron
    Department of Medicine, University of California, San Francisco, USA
    Cardiol Rev 7:156-60. 1999
    ....
  11. ncbi Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial
    B G Angeja
    Cardiovascular Division, University of California San Francisco, San Francisco, California 94143 0124, USA
    Am J Cardiol 88:1240-5. 2001
    ..33). Adjustment for small baseline differences in this randomized sample did not change the results. Thus, across the range of estimated weight categories corresponding to each TNK dose, TNK is as safe and effective as t-PA...
  12. ncbi The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project
    H V Barron
    Department of Epidemiology and Biostatistics and Medicine (Cardiology, University of California, San Francisco, San Francisco, California, USA
    J Am Coll Cardiol 38:1654-61. 2001
    ..Although the mechanism of the association remains speculative, the results of this study have important clinical implications for risk-stratifying patients with AMI...